Behavioral group therapy #1 for Opioid Use Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Icahn School of Medicine at Mount Sinai, New York, NYOpioid Use DisorderBehavioral group therapy #1 - Behavioral
Eligibility
18 - 64
All Sexes
What conditions do you have?
Select

Study Summary

This trial uses MRIs to study how different types of therapy affect the brains of people with opioid addiction, in hopes of finding better treatments.

Eligible Conditions
  • Opioid Use Disorder

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

6 Primary · 0 Secondary · Reporting Duration: baseline and 3 months enrollment

Month 3
Change in fMRI BOLD signal during tasks of reward
Month 3
Change in MRI Voxel-Based Morphometry (VBM) measure
Change in Urine drug test
Change in fMRI BOLD signal acquired during resting-state functional connectivity
Month 3
Change in fMRI BOLD signal for control reactivity
Change in fMRI BOLD signal for cue reactivity

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Behavioral group therapy 2
1 of 2
Behavioral group therapy 1
1 of 2

Active Control

Experimental Treatment

300 Total Participants · 2 Treatment Groups

Primary Treatment: Behavioral group therapy #1 · No Placebo Group · N/A

Behavioral group therapy 1
Behavioral
Experimental Group · 1 Intervention: Behavioral group therapy #1 · Intervention Types: Behavioral
Behavioral group therapy 2
Behavioral
ActiveComparator Group · 1 Intervention: Behavioral group therapy #2 · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and 3 months enrollment

Who is running the clinical trial?

Icahn School of Medicine at Mount SinaiLead Sponsor
789 Previous Clinical Trials
484,222 Total Patients Enrolled
National Center for Complementary and Integrative Health (NCCIH)NIH
787 Previous Clinical Trials
657,142 Total Patients Enrolled
University of UtahOTHER
1,008 Previous Clinical Trials
1,787,082 Total Patients Enrolled
Nelly Alia-Klein, PhDStudy DirectorIcahn School of Medicine at Mount Sinai
Rita Goldstein, PhDPrincipal Investigator - Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai

Eligibility Criteria

Age 18 - 64 · All Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You understand what the study is about and agree to participate in it.
You are currently taking methadone or other medication-assisted treatment (MAT) for opioid addiction and your treatment is stable.

Frequently Asked Questions

Is it permissible for octogenarians to participate in this experiment?

"Participants must be 18 years of age or older, but not exceed the upper limit of 64 for this clinical trial." - Anonymous Online Contributor

Unverified Answer

Is enrollment open for this medical experiment at present?

"Per information listed on clinicaltrials.gov, this medical study is still actively recruiting patients. The trial was first announced in October 2020 and received its latest update two years later to the date." - Anonymous Online Contributor

Unverified Answer

Could I potentially be included in this research program?

"Eligibility criteria for this heroin-focused study stipulates that applicants must be aged between 18 and 64. 300 total participants are required to complete the trial." - Anonymous Online Contributor

Unverified Answer

How many volunteers are partaking in this experiment?

"Correct. Clinicaltrials.gov's records indicate that this medical trial, which opened on October 21st 2020, is actively recruiting patients. 300 individuals are needed from one healthcare institution to take part in the experiment." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.